• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝炎和晚期肝病患者的心肺适能最低。

Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.

机构信息

Division of Gastroenterology & Hepatology, Department of Medicine, The Pennsylvania State University - Milton S. Hershey Medical Center, 500 University Drive, Hershey, PA, 17033, USA.

Department of Public Health Sciences, The Pennsylvania State University - Milton S. Hershey Medical Center, Hershey, PA, USA.

出版信息

Dig Dis Sci. 2023 Jun;68(6):2695-2703. doi: 10.1007/s10620-022-07809-w. Epub 2023 Jan 24.

DOI:10.1007/s10620-022-07809-w
PMID:36692803
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10566537/
Abstract

BACKGROUND & AIMS: Cardiorespiratory fitness and liver fibrosis are independently associated with poor outcomes in patients with nonalcoholic steatohepatitis (NASH), however, conflicting reports exist about their relationship. We aimed to better characterize the relationship between cardiorespiratory fitness and liver histology in a cross-sectional study of patients with biopsy-proven NASH.

METHODS

Participants aged 18-75 years completed VO fitness assessment using symptom-limited graded exercise testing. Participants were compared by liver fibrosis stage and NAFLD Activity Score (NAS). Multivariable models were constructed to assess factors related to relative VO, including liver fibrosis and NAS.

RESULTS

Thirty-five participants with mean age 48 ± 12 years and body mass index 33.5 ± 7.6 kg/m were enrolled. Seventy-four percent of participants were female and 49% had diabetes. A dose-dependent relationship was found between relative VO and liver fibrosis. Relative VO was significantly lower in participants with advanced fibrosis (F3 disease- 15.7 ± 5.3 vs. ≤ F2 disease- 20.7 ± 5.9 mL/kg/min, p = 0.027). NAS > 5 was also associated with lower relative VO (22.6 ± 5.7 vs. 16.5 ± 5.1 mL/kg/min, p = 0.012) compared to NAS ≤ 5. With multivariable modeling, advanced fibrosis remained independently predictive of relative VO while NAS trended towards significance.

DISCUSSION AND CONCLUSIONS

Advanced liver fibrosis is independently associated with cardiorespiratory fitness in patients with NASH. This may explain the incremental increase in mortality as liver fibrosis stage increases. Further research is needed to determine if exercise training can improve cardiorespiratory fitness across multiple stages of liver fibrosis and directly reduce morbidity and mortality in patients with NASH.

摘要

背景与目的

心肺适能和肝纤维化与非酒精性脂肪性肝炎(NASH)患者的不良结局独立相关,但它们之间的关系存在相互矛盾的报告。我们旨在通过对经活检证实的 NASH 患者进行横断面研究,更好地描述心肺适能与肝组织学之间的关系。

方法

年龄在 18-75 岁之间的参与者使用症状限制分级运动测试完成 VO 适应性评估。根据肝纤维化分期和 NAFLD 活动评分(NAS)对参与者进行比较。构建多变量模型来评估与相对 VO 相关的因素,包括肝纤维化和 NAS。

结果

共有 35 名参与者,平均年龄 48±12 岁,体重指数 33.5±7.6kg/m2。74%的参与者为女性,49%患有糖尿病。相对 VO 与肝纤维化之间存在剂量依赖性关系。纤维化程度较高(F3 期疾病-15.7±5.3 vs. ≤F2 期疾病-20.7±5.9mL/kg/min,p=0.027)的参与者相对 VO 显著降低。与 NAS≤5 相比,NAS>5 也与相对 VO 降低相关(22.6±5.7 vs. 16.5±5.1mL/kg/min,p=0.012)。在多变量模型中,肝纤维化的严重程度仍然是相对 VO 的独立预测因素,而 NAS 则呈趋势性。

讨论与结论

晚期肝纤维化与 NASH 患者的心肺适能独立相关。这可能解释了随着肝纤维化分期的增加,死亡率逐渐增加的原因。需要进一步的研究来确定运动训练是否可以改善多个肝纤维化阶段的心肺适能,并直接降低 NASH 患者的发病率和死亡率。

相似文献

1
Patients with Nonalcoholic Steatohepatitis and Advanced Liver Disease Have the Lowest Cardiorespiratory Fitness.非酒精性脂肪性肝炎和晚期肝病患者的心肺适能最低。
Dig Dis Sci. 2023 Jun;68(6):2695-2703. doi: 10.1007/s10620-022-07809-w. Epub 2023 Jan 24.
2
Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病 (NAFLD) 患者的活检率与非酒精性脂肪性肝炎 (NASH)。
Scand J Gastroenterol. 2020 Jun;55(6):706-711. doi: 10.1080/00365521.2020.1766554. Epub 2020 Jun 1.
3
Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study.基于网络的运动作为非酒精性脂肪性肝病患者的有效辅助治疗:干预性研究
J Med Internet Res. 2019 Jan 2;21(1):e11250. doi: 10.2196/11250.
4
Physical deconditioning is the common denominator in both obese and overweight subjects with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎的肥胖和超重患者都存在共同的身体失代偿因素。
Aliment Pharmacol Ther. 2018 Aug;48(3):290-299. doi: 10.1111/apt.14803. Epub 2018 May 24.
5
Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease.组织学疾病活动与非酒精性脂肪性肝病进展的关联。
JAMA Netw Open. 2019 Oct 2;2(10):e1912565. doi: 10.1001/jamanetworkopen.2019.12565.
6
IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.2 型糖尿病对非酒精性脂肪性肝病患者非酒精性脂肪性肝炎和肝纤维化进展的影响。
Endocr Pract. 2020 Apr;26(4):444-453. doi: 10.4158/EP-2019-0342. Epub 2020 Jan 22.
7
Low clinical relevance of the nonalcoholic fatty liver disease activity score (NAS) in predicting fibrosis progression.非酒精性脂肪性肝病活动评分(NAS)在预测纤维化进展方面的临床相关性较低。
Scand J Gastroenterol. 2012 Jan;47(1):108-15. doi: 10.3109/00365521.2011.634024. Epub 2011 Nov 30.
8
Steatohepatitis and liver fibrosis are predicted by the characteristics of very low density lipoprotein in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中极低密度脂蛋白的特征可预测脂肪性肝炎和肝纤维化。
Liver Int. 2016 Aug;36(8):1213-20. doi: 10.1111/liv.13076. Epub 2016 Feb 24.
9
Non-alcoholic fatty liver disease - histological scoring systems: a large cohort single-center, evaluation study.非酒精性脂肪性肝病——组织学评分系统:一项大型队列单中心评估研究。
APMIS. 2017 Nov;125(11):962-973. doi: 10.1111/apm.12742.
10
Serum bile acid patterns are associated with the presence of NAFLD in twins, and dose-dependent changes with increase in fibrosis stage in patients with biopsy-proven NAFLD.血清胆汁酸模式与双胞胎中非酒精性脂肪性肝病(NAFLD)的存在相关,并且在经活检证实的非酒精性脂肪性肝病患者中,随着纤维化阶段的增加,呈现出剂量依赖性变化。
Aliment Pharmacol Ther. 2019 Jan;49(2):183-193. doi: 10.1111/apt.15035. Epub 2018 Dec 2.

引用本文的文献

1
Co-designing Approaches to Sustainable Exercise Care for People with Metabolic Dysfunction-associated Steatotic Liver Disease.针对代谢功能障碍相关脂肪性肝病患者的可持续运动护理的协同设计方法
J Clin Transl Hepatol. 2025 Sep 28;13(9):707-722. doi: 10.14218/JCTH.2025.00155. Epub 2025 Aug 21.
2
AMPED study: Protocol for a randomized controlled trial of different doses of aerobic exercise training.AMPED 研究:不同剂量有氧运动训练的随机对照试验方案。
Hepatol Commun. 2024 Jun 19;8(7). doi: 10.1097/HC9.0000000000000464. eCollection 2024 Jul 1.
3
Untangling frailty, sarcopenia, and physical fitness in cirrhosis.解析肝硬化中的衰弱、肌肉减少症和体能状况
Clin Liver Dis (Hoboken). 2024 Jun 5;23(1):e0213. doi: 10.1097/CLD.0000000000000213. eCollection 2024 Jan-Jun.
4
Lifestyle intervention for metabolic dysfunction-associated fatty liver disease: a 24-h integrated behavior perspective.生活方式干预治疗代谢相关脂肪性肝病:24 小时综合行为观点
Hepatol Int. 2024 Oct;18(Suppl 2):959-976. doi: 10.1007/s12072-024-10663-9. Epub 2024 May 8.
5
Exercise Is Medicine for Nonalcoholic Fatty Liver Disease: Exploration of Putative Mechanisms.运动是治疗非酒精性脂肪肝的良药:潜在机制的探索。
Nutrients. 2023 May 24;15(11):2452. doi: 10.3390/nu15112452.
6
Physical Activity and Nonalcoholic Fatty Liver Disease: A Roundtable Statement from the American College of Sports Medicine.体力活动与非酒精性脂肪性肝病:美国运动医学学会圆桌会议声明。
Med Sci Sports Exerc. 2023 Sep 1;55(9):1717-1726. doi: 10.1249/MSS.0000000000003199.
7
Serum Fibroblast Growth Factor 21 Is Markedly Decreased following Exercise Training in Patients with Biopsy-Proven Nonalcoholic Steatohepatitis.经肝活检证实的非酒精性脂肪性肝炎患者经运动训练后血清成纤维细胞生长因子 21 明显下降。
Nutrients. 2023 Mar 20;15(6):1481. doi: 10.3390/nu15061481.

本文引用的文献

1
Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease.打破非酒精性脂肪性肝病患者身体活动障碍。
Dig Dis Sci. 2021 Oct;66(10):3604-3611. doi: 10.1007/s10620-020-06673-w. Epub 2020 Oct 23.
2
Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH.非酒精性脂肪性肝炎血栓形成的健身干预(NASHFit):一项关于监督有氧运动计划以降低非酒精性脂肪性肝炎患者凝血风险升高的随机对照试验的研究方案。
Contemp Clin Trials Commun. 2020 Apr 4;18:100560. doi: 10.1016/j.conctc.2020.100560. eCollection 2020 Jun.
3
AGA Clinical Practice Update on Screening and Surveillance for Hepatocellular Carcinoma in Patients With Nonalcoholic Fatty Liver Disease: Expert Review.AGA 临床实践更新:非酒精性脂肪性肝病患者肝细胞癌的筛查和监测:专家综述。
Gastroenterology. 2020 May;158(6):1822-1830. doi: 10.1053/j.gastro.2019.12.053. Epub 2020 Jan 30.
4
Multicenter Validation of Association Between Decline in MRI-PDFF and Histologic Response in NASH.多中心验证 MRI-PDFF 下降与 NASH 组织学应答的相关性。
Hepatology. 2020 Oct;72(4):1219-1229. doi: 10.1002/hep.31121. Epub 2020 Oct 9.
5
Nonalcoholic Fatty Liver Disease and Fibrosis Associated With Increased Risk of Cardiovascular Events in a Prospective Study.非酒精性脂肪性肝病和纤维化与前瞻性研究中心血管事件风险增加相关。
Clin Gastroenterol Hepatol. 2020 Sep;18(10):2324-2331.e4. doi: 10.1016/j.cgh.2019.12.026. Epub 2019 Dec 27.
6
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.奥贝胆酸治疗非酒精性脂肪性肝炎:多中心、随机、安慰剂对照 3 期临床试验的中期分析。
Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5.
7
Reduced physical activity in young and older adults: metabolic and musculoskeletal implications.年轻人和老年人身体活动减少:对代谢和肌肉骨骼的影响
Ther Adv Endocrinol Metab. 2019 Nov 19;10:2042018819888824. doi: 10.1177/2042018819888824. eCollection 2019.
8
Non-alcoholic fatty liver disease: Prevalence and all-cause mortality according to sedentary behaviour and cardiorespiratory fitness. The HUNT Study.非酒精性脂肪性肝病:基于静坐行为和心肺适能的流行率和全因死亡率。亨于尔特研究。
Prog Cardiovasc Dis. 2019 Mar-Apr;62(2):127-134. doi: 10.1016/j.pcad.2019.01.005. Epub 2019 Feb 21.
9
Relation of Hepatic Fibrosis in Nonalcoholic Fatty Liver Disease to Left Ventricular Diastolic Function and Exercise Tolerance.非酒精性脂肪性肝病肝纤维化与左心室舒张功能和运动耐量的关系。
Am J Cardiol. 2019 Feb 1;123(3):466-473. doi: 10.1016/j.amjcard.2018.10.027. Epub 2018 Nov 6.
10
Cardiorespiratory Fitness and Mortality in Healthy Men and Women.心肺适能与健康男女的死亡率。
J Am Coll Cardiol. 2018 Nov 6;72(19):2283-2292. doi: 10.1016/j.jacc.2018.08.2166.